source
- FDA approves Regeneron’s hearing loss gene therapyOtarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s “national priority” voucher program and will be offered to eligible patients…BioPharma Dive · 3mo ago↗ source
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campusThe 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.BioPharma Dive · 3mo ago↗ source
- Roche, facing biosimilar threats, puts faith in new cancer and obesity drugsOn a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.